ARTICLE | Company News
Interprotein, Ipsen deal
November 23, 2015 8:00 AM UTC
Ipsen and Interprotein partnered to develop therapeutic peptides to treat endocrine diseases, including Cushing’s disease. Ipsen will have an exclusive option to license candidates developed during th...